Medical experts report rising lung cancer diagnoses in non-smokers as smoking rates decline, raising questions about ...

DURING SCREENING SEASON, which runs from March to December, LUCAS sets off on Mondays from the cancer institute in Morgantown ...

Cancer rates are rising among younger people aged under 50. Here’s what we know about the causes – and what the evidence says ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

Eight years after it was established partly by AstraZeneca, Dizal Pharmaceuticals has gained its first FDA approval, winning an accelerated nod for Zegfrovy (sunvozertinib) to become the only ...

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...

Australia’s new lung cancer screen program further disadvantages Aboriginal and Torres Strait Islander peoples, who are ...

NEW YORK – The US Food and Drug Administration on Wednesday granted accelerated approval to Dizal's oral EGFR inhibitor Zegfrovy (sunvozertinib) as a treatment for patients with locally advanced or ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Breast cancer is the most common type of cancer in women, while prostate, which President Joe Biden was just diagnosed with, is most common for men.